5014 related articles for article (PubMed ID: 1917148)
1. Characterization of gangliosides in human uveal melanoma cells.
Soulieres D; Rousseau A; Deschenes J; Tremblay M; Tardif M; Pelletier G
Int J Cancer; 1991 Oct; 49(4):498-503. PubMed ID: 1917148
[TBL] [Abstract][Full Text] [Related]
2. Variations in the ganglioside profile of uveal melanoma correlate with cytologic heterogeneity.
Kanda S; Cochran AJ; Lee WR; Morton DL; Irie RF
Int J Cancer; 1992 Nov; 52(5):682-7. PubMed ID: 1428227
[TBL] [Abstract][Full Text] [Related]
3. Effect of anti-ganglioside antibodies on the metastatic spread of intraocular melanomas in a nude mouse model of human uveal melanoma.
Niederkorn JY; Mellon J; Pidherney M; Mayhew E; Anand R
Curr Eye Res; 1993 Apr; 12(4):347-58. PubMed ID: 8319494
[TBL] [Abstract][Full Text] [Related]
4. Gangliosides in human uveal melanoma metastatic process.
Tardif M; Coulombe J; Soulières D; Rousseau AP; Pelletier G
Int J Cancer; 1996 Sep; 68(1):97-101. PubMed ID: 8895547
[TBL] [Abstract][Full Text] [Related]
5. Gangliosides of human melanoma.
Tsuchida T; Saxton RE; Morton DL; Irie RF
J Natl Cancer Inst; 1987 Jan; 78(1):45-54. PubMed ID: 3467129
[TBL] [Abstract][Full Text] [Related]
6. Differential roles of gangliosides in malignant properties of melanomas.
Ohmi Y; Kambe M; Ohkawa Y; Hamamura K; Tajima O; Takeuchi R; Furukawa K; Furukawa K
PLoS One; 2018; 13(11):e0206881. PubMed ID: 30462668
[TBL] [Abstract][Full Text] [Related]
7. Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography.
Hamilton WB; Helling F; Lloyd KO; Livingston PO
Int J Cancer; 1993 Feb; 53(4):566-73. PubMed ID: 8436430
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of gangliosides in human renal cell carcinomas.
Hoon DS; Okun E; Neuwirth H; Morton DL; Irie RF
J Urol; 1993 Dec; 150(6):2013-8. PubMed ID: 8230555
[TBL] [Abstract][Full Text] [Related]
9. Cell surface accessibility of individual gangliosides in malignant melanoma cells to antibodies is influenced by the total ganglioside composition of the cells.
Lloyd KO; Gordon CM; Thampoe IJ; DiBenedetto C
Cancer Res; 1992 Sep; 52(18):4948-53. PubMed ID: 1516051
[TBL] [Abstract][Full Text] [Related]
10. Glycosylation pathways in the biosynthesis of gangliosides in melanoma and neuroblastoma cells: relative glycosyltransferase levels determine ganglioside patterns.
Ruan S; Lloyd KO
Cancer Res; 1992 Oct; 52(20):5725-31. PubMed ID: 1394196
[TBL] [Abstract][Full Text] [Related]
11. Antibody response after immunization with the gangliosides GM1, GM2, GM3, GD2 and GD3 in the mouse.
Livingston PO; Ritter G; Calves MJ
Cancer Immunol Immunother; 1989; 29(3):179-84. PubMed ID: 2731184
[TBL] [Abstract][Full Text] [Related]
12. Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies.
Furukawa K; Yamaguchi H; Oettgen HF; Old LJ; Lloyd KO
Cancer Res; 1989 Jan; 49(1):191-6. PubMed ID: 2908845
[TBL] [Abstract][Full Text] [Related]
13. Ganglioside composition and its relation to clinical data in brain tumors.
Shinoura N; Dohi T; Kondo T; Yoshioka M; Takakura K; Oshima M
Neurosurgery; 1992 Sep; 31(3):541-9. PubMed ID: 1407435
[TBL] [Abstract][Full Text] [Related]
14. Gangliosides of human melanoma: GM2 and tumorigenicity.
Tsuchida T; Saxton RE; Irie RF
J Natl Cancer Inst; 1987 Jan; 78(1):55-60. PubMed ID: 3467130
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of integrins in vitro and in vivo in uveal and cutaneous melanomas.
Marshall JF; Rutherford DC; Happerfield L; Hanby A; McCartney AC; Newton-Bishop J; Hart IR
Br J Cancer; 1998 Feb; 77(4):522-9. PubMed ID: 9484806
[TBL] [Abstract][Full Text] [Related]
16. Ganglioside signatures of primary and nodal metastatic melanoma cell lines from the same patient.
Ravindranath MH; Muthugounder S; Presser N
Melanoma Res; 2008 Feb; 18(1):47-55. PubMed ID: 18227708
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of melanoma-associated gangliosides in cancer patients.
Tai T; Cahan LD; Tsuchida T; Saxton RE; Irie RF; Morton DL
Int J Cancer; 1985 May; 35(5):607-12. PubMed ID: 3997282
[TBL] [Abstract][Full Text] [Related]
18. Expression of the gangliosides GM3, GD3 and GD2 in tissue sections of normal skin, naevi, primary and metastatic melanoma.
Hersey P; Jamal O; Henderson C; Zardawi I; D'Alessandro G
Int J Cancer; 1988 Mar; 41(3):336-43. PubMed ID: 3346097
[TBL] [Abstract][Full Text] [Related]
19. Correlation of gangliosides GM2 and GM3 with metastatic potential to lungs of mouse B16 melanoma.
Saha S; Mohanty KC
J Exp Clin Cancer Res; 2003 Mar; 22(1):125-34. PubMed ID: 12725332
[TBL] [Abstract][Full Text] [Related]
20. Ganglioside GM3:GD3 ratio as an index for the management of melanoma.
Ravindranath MH; Tsuchida T; Morton DL; Irie RF
Cancer; 1991 Jun; 67(12):3029-35. PubMed ID: 2044049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
